Early Detection Biomarkers | Nexomic Limited



Early detection biomarkers developed by Nexomic Limited allow clinicians to identify diseases at the earliest stages, improving prognosis and enabling timely intervention through advanced AI-driven multi-omics analysis.

https://nexomic.com/

ESMO 2025: AI biomarkers move from promise to practice

At this year’s ESMO Congress in Berlin, one message was clear: AI-based biomarkers are exiting the lab and entering real clinical decisions. From digital pathology to CT radiomics and multi-omics, teams showed practical ways to read response earlier and adapt treatment more precisely.



https://nexomic.com/blog/esmo-....2025-ai-biomarkers-m

Meet Nexomic at Biomarkers & Precision Medicine Conference

The Precision Medicine Awards were created to highlight innovation and collaboration in the field of personalized healthcare. They bring together scientists, clinicians, technologists, and entrepreneurs who are working to change the way care is delivered.



https://nexomic.com/blog/meet-....nexomic-at-biomarker

Ai Multi-omics | Nexomic Limited



AI multi-omics solutions from Nexomic Limited harness the power of artificial intelligence across multiple omics layers to uncover critical disease mechanisms, predict therapy response, and accelerate biomarker discovery for precision healthcare.

https://nexomic.com/

Ai Multi-omics | Nexomic Limited

AI multi-omics solutions from Nexomic Limited harness the power of artificial intelligence across multiple omics layers to uncover critical disease mechanisms, predict therapy response, and accelerate biomarker discovery for precision healthcare.

https://nexomic.com/